JP2007525465A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007525465A5 JP2007525465A5 JP2006514911A JP2006514911A JP2007525465A5 JP 2007525465 A5 JP2007525465 A5 JP 2007525465A5 JP 2006514911 A JP2006514911 A JP 2006514911A JP 2006514911 A JP2006514911 A JP 2006514911A JP 2007525465 A5 JP2007525465 A5 JP 2007525465A5
- Authority
- JP
- Japan
- Prior art keywords
- antibodies
- htnf
- fragments
- bind
- regions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/441,059 US7892563B2 (en) | 2003-05-20 | 2003-05-20 | Methods for treatment of severe acute respiratory syndrome (SARS) |
| PCT/US2004/015864 WO2005018535A2 (en) | 2003-05-20 | 2004-05-20 | Compositions and methods for treatment of severe acute respiratory syndrome (sars) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007525465A JP2007525465A (ja) | 2007-09-06 |
| JP2007525465A5 true JP2007525465A5 (enExample) | 2008-01-24 |
Family
ID=33449934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006514911A Pending JP2007525465A (ja) | 2003-05-20 | 2004-05-20 | 重症急性呼吸症候群（ｓａｒｓ）の治療のための、組成物および方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7892563B2 (enExample) |
| EP (1) | EP1624850A4 (enExample) |
| JP (1) | JP2007525465A (enExample) |
| KR (1) | KR20060023968A (enExample) |
| CN (1) | CN1976720A (enExample) |
| AU (1) | AU2004266111B8 (enExample) |
| BR (1) | BRPI0410467A (enExample) |
| CA (1) | CA2526431A1 (enExample) |
| IL (1) | IL171972A0 (enExample) |
| MX (1) | MXPA05012497A (enExample) |
| NO (1) | NO20056073L (enExample) |
| NZ (1) | NZ543655A (enExample) |
| RU (1) | RU2411042C2 (enExample) |
| WO (1) | WO2005018535A2 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9028822B2 (en) | 2002-06-28 | 2015-05-12 | Domantis Limited | Antagonists against TNFR1 and methods of use therefor |
| US20080008713A1 (en) * | 2002-06-28 | 2008-01-10 | Domantis Limited | Single domain antibodies against tnfr1 and methods of use therefor |
| NZ561879A (en) | 2003-03-07 | 2009-05-31 | Wyeth Corp | Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| JP4845091B2 (ja) * | 2005-08-09 | 2011-12-28 | 学校法人日本大学 | コロナウィルスの遺伝子を切断するリボザイム |
| AU2007314542A1 (en) * | 2006-05-08 | 2008-05-08 | University Of Virginia Patent Foundation | Compositions and methods for treating anthrax lethality |
| EP2043603A4 (en) * | 2006-07-11 | 2010-10-27 | Arubor Corp | PREVENTION AND THERAPY OF RHINOSINUSITIS WITH PROINFLAMMATORY CYTOKINHERMERS |
| CA2782320A1 (en) * | 2009-12-02 | 2011-06-09 | Acceleron Pharma Inc. | Compositions and methods for increasing serum half-life of fc fusion proteins |
| WO2012157751A1 (ja) * | 2011-05-19 | 2012-11-22 | 持田製薬株式会社 | 尿検体を用いた呼吸器感染症の診断 |
| WO2012170938A1 (en) | 2011-06-08 | 2012-12-13 | Acceleron Pharma Inc. | Compositions and methods for increasing serum half-life |
| CN111228480A (zh) * | 2020-02-24 | 2020-06-05 | 浙江正熙生物医药有限公司 | 抗人TNF-α抗体在制备用于治疗病毒感染的药物中的应用 |
| BR112022017986A2 (pt) | 2020-03-09 | 2022-12-13 | Abcellera Biologics Inc | Anticorpos anticoronavírus e métodos de uso |
| CN115996741A (zh) * | 2020-03-11 | 2023-04-21 | 百欧林纳克斯有限公司 | 用于治疗急性呼吸窘迫综合征及病毒感染的cxcr4抑制剂 |
| WO2021186439A1 (en) * | 2020-03-16 | 2021-09-23 | Bar-Ilan University | Molecules that target proteins of coronaviruses and uses thereof as anti-viral "cocktail" |
| CN113425722B (zh) * | 2020-03-23 | 2025-06-24 | 上海市浦东新区公利医院(第二军医大学附属公利医院) | 苦味受体激动剂及其在预防和治疗SARS-CoV-2相关传染病中的应用 |
| CR20220552A (es) | 2020-04-02 | 2023-01-17 | Regeneron Pharma | Anticuerpos contra glicoproteína de espícula anti-sars-cov-2 y fragmentos de unión al antígeno |
| KR102689822B1 (ko) * | 2020-04-03 | 2024-07-29 | 베루 인코퍼레이티드 | 코로나바이러스의 치료 방법 |
| CN115666569A (zh) * | 2020-04-08 | 2023-01-31 | 诺斯楚姆制药有限责任公司 | 用于预防和/或治疗病毒感染或其相关病状的组成物和方法 |
| TW202204375A (zh) * | 2020-04-15 | 2022-02-01 | 美商寇峇有限公司 | 治療冠狀病毒感染之方法 |
| IL274327A (en) * | 2020-04-28 | 2021-10-31 | Zaltzman Pinchas | Antiviral preparations |
| EP3906922A1 (en) * | 2020-05-07 | 2021-11-10 | 4Living Biotech | New compositions and methods of treating covid-19 disease |
| EP4146343A4 (en) * | 2020-05-07 | 2024-05-29 | Bio-Rad Laboratories, Inc. | SARS-COV-2 IMMUNOASSAY AND MATERIALS THEREFOR |
| WO2021231930A1 (en) * | 2020-05-15 | 2021-11-18 | Altered Labs Llc | Immune booster supplement treatment kit and methods of use |
| WO2022020234A2 (en) * | 2020-07-20 | 2022-01-27 | Bio-Rad Laboratories, Inc. | Immunoassay for sars-cov-2 neutralizing antibodies and materials therefor |
| EP3957364A1 (en) * | 2020-08-20 | 2022-02-23 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | A binding molecule specifically binding to human cd4 for use in the treatment of pulmonary diseases |
| US20220273641A1 (en) * | 2020-10-07 | 2022-09-01 | Vera Mikhailov | Method for treating coronavirus infections including SARS-CoV-2 |
| WO2022264097A1 (en) * | 2021-06-17 | 2022-12-22 | Lupin Limited | Pharmaceutical composition of anti-tumour necrosis factor (anti-tnf) agent for management of infectious diseases caused by coronaviruses |
| WO2023287875A1 (en) | 2021-07-14 | 2023-01-19 | Regeneron Pharmaceuticals, Inc. | Anti-sars-cov-2-spike glycoprotein antibodies and antigen-binding fragments |
Family Cites Families (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
| EP0173494A3 (en) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric receptors by dna splicing and expression |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| US4699880A (en) | 1984-09-25 | 1987-10-13 | Immunomedics, Inc. | Method of producing monoclonal anti-idiotype antibody |
| US4720489A (en) | 1984-10-15 | 1988-01-19 | Douglas Shander | Hair growth modification with ornithine decarboxylase inhibitors |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| EP0212489B1 (en) | 1985-08-16 | 1994-11-30 | The Rockefeller University | Anabolic activity modulator and uses thereof |
| US4870163A (en) | 1985-08-29 | 1989-09-26 | New York Blood Center, Inc. | Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor |
| US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
| US5116742A (en) | 1986-12-03 | 1992-05-26 | University Patents, Inc. | RNA ribozyme restriction endoribonucleases and methods |
| US5196430A (en) | 1986-12-31 | 1993-03-23 | Hoechst-Roussel Pharmaceuticals Inc. | Method of inhibiting the activity of leukocyte derived cytokines |
| US5096906A (en) | 1986-12-31 | 1992-03-17 | University Of Virginia Alumni Patents Foundation | Method of inhibiting the activity of leukocyte derived cytokines |
| JP2647427B2 (ja) | 1987-04-24 | 1997-08-27 | 帝人株式会社 | 被検者の病態の判定のための検出方法、モノクロ−ナル抗体および検出キット |
| US4904582A (en) | 1987-06-11 | 1990-02-27 | Synthetic Genetics | Novel amphiphilic nucleic acid conjugates |
| IL83878A (en) | 1987-09-13 | 1995-07-31 | Yeda Res & Dev | Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it |
| DE3817955A1 (de) | 1988-05-27 | 1989-11-30 | Hoechst Ag | Tnf-inhibitor enthaltendes arzneimittel |
| IL94039A (en) | 1989-08-06 | 2006-09-05 | Yeda Res & Dev | Antibodies to tbp - 1 and their use |
| AU636608B2 (en) | 1989-05-18 | 1993-05-06 | Yeda Research And Development Co. Ltd. | Tumor necrosis factor binding protein II, it's purification and antibodies thereto |
| GB9413975D0 (en) | 1994-07-11 | 1994-08-31 | Fujisawa Pharmaceutical Co | New heterobicyclic derivatives |
| EP0486526B2 (en) | 1989-08-07 | 2001-03-07 | Peptech Limited | Tumour necrosis factor binding ligands |
| US5605690A (en) | 1989-09-05 | 1997-02-25 | Immunex Corporation | Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor |
| US5395760A (en) | 1989-09-05 | 1995-03-07 | Immunex Corporation | DNA encoding tumor necrosis factor-α and -β receptors |
| EP0433900B1 (en) | 1989-12-13 | 1995-09-20 | Yeda Research And Development Company Limited | Expression of the recombinant tumor necrosis factor binding protein I (TBP-I) |
| DE4027616A1 (de) | 1990-08-31 | 1992-03-05 | Boehringer Mannheim Gmbh | Verfahren zur bestimmung von polymerase-aktivitaet |
| GB9022648D0 (en) | 1990-10-18 | 1990-11-28 | Charing Cross Sunley Research | Polypeptide and its use |
| GB9109645D0 (en) | 1991-05-03 | 1991-06-26 | Celltech Ltd | Recombinant antibodies |
| GB9028123D0 (en) | 1990-12-28 | 1991-02-13 | Erba Carlo Spa | Monoclonal antibodies against human tumor necrosis factor alpha |
| SG63617A1 (en) | 1991-01-18 | 1999-03-30 | Amgen Boulder Inc | Methods for treating tumar necrosis factor mediated diseases |
| US5656272A (en) | 1991-03-18 | 1997-08-12 | New York University Medical Center | Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies |
| US6277969B1 (en) | 1991-03-18 | 2001-08-21 | New York University | Anti-TNF antibodies and peptides of human tumor necrosis factor |
| EP0593585B1 (en) | 1991-07-05 | 2002-05-02 | Peptech Limited | Peptide which abrogates tnf and lps toxicity |
| IL99120A0 (en) | 1991-08-07 | 1992-07-15 | Yeda Res & Dev | Multimers of the soluble forms of tnf receptors,their preparation and pharmaceutical compositions containing them |
| US5547979A (en) | 1992-03-30 | 1996-08-20 | Smithkline Beecham | TNF inhibition |
| GB9223904D0 (en) | 1992-11-13 | 1993-01-06 | British Bio Technology | Inhibition of cytokine production |
| US5594106A (en) | 1993-08-23 | 1997-01-14 | Immunex Corporation | Inhibitors of TNF-α secretion |
| GB9320660D0 (en) | 1993-10-07 | 1993-11-24 | British Bio Technology | Inhibition of cytokine production |
| US5508300A (en) | 1994-01-14 | 1996-04-16 | Pfizer Inc. | Dihydro pyrazolopyrroles, compositions and use |
| ATE165817T1 (de) | 1994-01-20 | 1998-05-15 | British Biotech Pharm | Metalloproteinaseinhibitoren |
| GB9412672D0 (en) | 1994-06-23 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| CA2192821A1 (en) | 1994-06-24 | 1996-01-04 | Wayne R. Gombotz | Controlled release polypeptide compositions and methods of treating inflammatory bowel disease |
| GB2291422A (en) | 1994-07-18 | 1996-01-24 | Fujisawa Pharmaceutical Co | 4-phenyl-pyrido[2,3-b]pyrazin-4-ones |
| US5563143A (en) | 1994-09-21 | 1996-10-08 | Pfizer Inc. | Catechol diether compounds as inhibitors of TNF release |
| US6107273A (en) | 1995-01-24 | 2000-08-22 | Thomas Jefferson University | Tumor necrosis factor inhibitors |
| IL112834A (en) | 1995-03-01 | 2000-12-06 | Yeda Res & Dev | Pharmaceutical compositions for controlled release of soluble receptors |
| US5863949A (en) | 1995-03-08 | 1999-01-26 | Pfizer Inc | Arylsulfonylamino hydroxamic acid derivatives |
| MX9708026A (es) | 1995-04-20 | 1997-11-29 | Pfizer | Derivados del acido arislfulfonil hidroxamico, composiciones que los contienen y uso de los mismos. |
| US5824519A (en) | 1995-11-08 | 1998-10-20 | Medical University Of South Carolina | Tissue-specific and target RNA-specific ribozymes |
| GB9607120D0 (en) | 1996-04-04 | 1996-06-12 | Chiroscience Ltd | Compounds |
| BR9709105A (pt) | 1996-05-20 | 1999-08-03 | Darwin Discovery Ltd | Sulfonamidas de quinolina como inibidoras de tnf e como inobidoras de pde-iv |
| AU4988697A (en) | 1996-10-24 | 1998-05-15 | Vion Pharmaceuticals, Inc. | Monophosphate prodrugs of beta-l-fd4c and beta-l-fddc as potent antiviral agents |
| US5833994A (en) | 1997-01-08 | 1998-11-10 | Paracelsian, Inc. | Use of the AH receptor and AH receptor ligands to treat or prevent cytopathicity of viral infection |
| WO1998050347A1 (en) | 1997-05-05 | 1998-11-12 | The Regents Of The University Of California | Naphthols useful in antiviral methods |
| US6071743A (en) | 1997-06-02 | 2000-06-06 | Subsidiary No. 3, Inc. | Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| US5883131A (en) | 1997-07-09 | 1999-03-16 | Pfizer Inc. | Cyclic sulfone derivatives |
| AU9013998A (en) | 1997-07-21 | 1999-02-10 | Zymogenetics Inc. | Tumor necrosis factor receptor ztnfr-5 |
| JP2001517666A (ja) | 1997-09-23 | 2001-10-09 | 藤沢薬品工業株式会社 | チアゾール誘導体 |
| US6020339A (en) | 1997-10-03 | 2000-02-01 | Merck & Co., Inc. | Aryl furan derivatives as PDE IV inhibitors |
| DE19813802A1 (de) | 1998-03-27 | 1999-11-11 | Retro Tech Gmbh | Anti-virale Wirkung von Propolis durch Inhibition viraler Nukleinsäure Polymerasen |
| US6251868B1 (en) | 1998-04-30 | 2001-06-26 | Teijin Limited | Method for treating a human immunodeficiency virus infection |
| MXPA00012842A (es) | 1998-06-24 | 2004-06-22 | Univ Emory | Uso de 3'-azido-2',3'-didesoxiuridina en combinacion de drogas adicionales contra el vih para la manufactura de un medicamento para el tratamiento del vih. |
| WO2000009150A2 (en) | 1998-08-17 | 2000-02-24 | Prendergast Patrick T | Cytokine and cytokine receptor, agonist, antagonist and/or antibody combination for therapeutic use |
| US6080580A (en) | 1998-10-05 | 2000-06-27 | Isis Pharmaceuticals Inc. | Antisense oligonucleotide modulation of tumor necrosis factor-α (TNF-α) expression |
| US6114517A (en) | 1998-12-10 | 2000-09-05 | Isis Pharmaceuticals Inc. | Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules |
| US6419934B1 (en) * | 1999-02-24 | 2002-07-16 | Edward L. Tobinick | TNF modulators for treating neurological disorders associated with viral infection |
| SG101418A1 (en) * | 1999-03-30 | 2004-01-30 | Showa Denko Kk | Production process for magnetic recording medium |
| US20010021380A1 (en) | 1999-04-19 | 2001-09-13 | Pluenneke John D. | Soluble tumor necrosis factor receptor treatment of medical disorders |
| US6632667B1 (en) * | 1999-10-28 | 2003-10-14 | Isis Pharmaceuticals, Inc. | Modulation of L-selectin shedding via inhibition of tumor necrosis factor-α converting enzyme (TACE) |
| US7056695B2 (en) * | 2000-03-02 | 2006-06-06 | Xencor | TNF-α variants |
| CA2385745C (en) * | 2001-06-08 | 2015-02-17 | Abbott Laboratories (Bermuda) Ltd. | Methods of administering anti-tnf.alpha. antibodies |
-
2003
- 2003-05-20 US US10/441,059 patent/US7892563B2/en not_active Expired - Lifetime
-
2004
- 2004-05-20 RU RU2005139730/15A patent/RU2411042C2/ru not_active IP Right Cessation
- 2004-05-20 EP EP04776064A patent/EP1624850A4/en not_active Withdrawn
- 2004-05-20 KR KR1020057022091A patent/KR20060023968A/ko not_active Ceased
- 2004-05-20 JP JP2006514911A patent/JP2007525465A/ja active Pending
- 2004-05-20 AU AU2004266111A patent/AU2004266111B8/en not_active Ceased
- 2004-05-20 US US10/557,479 patent/US7722886B2/en not_active Expired - Lifetime
- 2004-05-20 WO PCT/US2004/015864 patent/WO2005018535A2/en not_active Ceased
- 2004-05-20 MX MXPA05012497A patent/MXPA05012497A/es unknown
- 2004-05-20 CN CNA200480013748XA patent/CN1976720A/zh active Pending
- 2004-05-20 BR BRPI0410467-6A patent/BRPI0410467A/pt not_active IP Right Cessation
- 2004-05-20 NZ NZ543655A patent/NZ543655A/en not_active IP Right Cessation
- 2004-05-20 CA CA002526431A patent/CA2526431A1/en not_active Abandoned
-
2005
- 2005-11-15 IL IL171972A patent/IL171972A0/en unknown
- 2005-12-20 NO NO20056073A patent/NO20056073L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007525465A5 (enExample) | ||
| PT1322960E (pt) | Ensaio de micro-arranjos de alergenios | |
| EA200800812A1 (ru) | Композиции антитела против cd3 | |
| ES2572177T3 (es) | Anticuerpos neutralizantes anti-B7RP1 humanos | |
| NO20073655L (no) | Antistoffer mot IL-13 reseptor alfa 1 og anvendelser derav | |
| WO2010010466A3 (en) | Neutralizing anti-influenza a virus antibodies and uses thereof | |
| EP2295465A3 (en) | Human monoclonal antibodies to influenza M2 protein and methods of making and using same | |
| IL222756A0 (en) | Antibodies and antigen-binding fragments thereof that bind to a sclerostin polypeptide, compositions containing the same and methods for the production thereof | |
| WO2010009987A3 (en) | Diagnostic antibody assay | |
| JP2010515717A5 (enExample) | ||
| ZA200702879B (en) | Single domain antibodies against TNFR1 and methods of use therefor | |
| WO2006086208A3 (en) | 5-fluoro-uracil immunoassay | |
| WO2003078600A3 (en) | Human monoclonal antibodies to influenza m2 protein and methods of making and using same | |
| MX2009005103A (es) | Conjugado anti-idiotipo y su uso como un estandar en un inmunoensayo. | |
| EP3300739A3 (en) | Antibodies and related molecules that bind to 161p2f10b proteins | |
| WO2005030806A3 (en) | Norovirus monoclonal antibodies and peptides | |
| WO2006015098A3 (en) | Taxol immunoassay | |
| ATE458006T1 (de) | Humaner monoklonaler antikörper spezifisch für lipopolysacchariden (lps) des serotyps iats o6 von pseudomonas aeruginosa | |
| WO2006091421A3 (en) | Peptides for detection of antibody to ehrlichia ewingii | |
| NO20051715L (no) | HCV assay | |
| WO2008156704A3 (en) | Antibody-mediated modulation of allergy | |
| DE602006016736D1 (de) | Für lipopolysaccharide (lps) des pseudomonas aeruginosa-iats-o11-serotyps spezifische humane monoklonale antikörper | |
| WO2005000896A3 (en) | Polypeptides that bind an anti-tissue factor antibody and uses thereof | |
| JP2007505320A5 (enExample) | ||
| WO2006026508A3 (en) | Modified hiv-1 envelope proteins |